Coagulants
- Active ingredient (INN)
- heparin sodium
- Composition (active ingredients)
- sodium heparin - 5000 IU
- Фармакотерапевтическая группа
- direct acting anticoagulant
- Pharmacotherapeutic group
- ampoules 5000 IU/ml 5 ml №5
- Сonditions of supply
- on prescription
Indications
Indications
- prevention and treatment of venous thrombosis (including thrombosis of superficial and deep veins of the lower extremities, renal vein thrombosis) and pulmonary embolism;
- prevention and treatment of thromboembolic complications associated with atrial fibrillation;
- prevention and treatment of peripheral arterial embolism (including those associated with mitral heart disease);
- treatment of acute and chronic consumption coagulopathies (including stage I DIC syndrome);
- acute coronary syndrome without sustained ST-segment elevation on ECG (unstable angina pectoris, myocardial infarction without ST-segment elevation on ECG);
- ST-segment elevation myocardial infarction with thrombolytic therapy, with primary percutaneous coronary revascularization (balloon angioplasty with or without stenting) and with a high risk of arterial or venous thrombosis and thromboembolism;
- prevention and treatment of microthrombus formation and microcirculation disorders, including hemolytic uremic syndrome, glomerulonephritis (including lupus nephritis) and forced diuresis;
- prevention of blood clotting during blood transfusion, in extracorporeal circulation systems (extracorporeal circulation during heart surgery, hemosorption, cytapheresis) and during hemodialysis;
- treatment of peripheral venous catheters.
Contraindications
There are contraindications, consult with a specialist before use
